SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001714899-23-000049
Filing Date
2023-02-27
Accepted
2023-02-27 16:06:32
Documents
101
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K dnli-20221231.htm   iXBRL 10-K 2685359
2 EX-4.4 exhibit44q42022description.htm EX-4.4 29878
3 EX-10.127 amendmentno7todevelopmenta.htm EX-10.127 22459
4 EX-10.128 amendmentno8todevelopmenta.htm EX-10.128 63791
5 EX-10.129 amendmentno9todevelopmenta.htm EX-10.129 23980
6 EX-21.1 exhibit211q42022subsidiari.htm EX-21.1 3042
7 EX-23.1 exhibit231q42022.htm EX-23.1 5215
8 EX-31.1 exhibit311q42022.htm EX-31.1 9996
9 EX-31.2 exhibit312q42022.htm EX-31.2 10016
10 EX-32.1 exhibit321q42022.htm EX-32.1 5657
11 EX-32.2 exhibit322q42022.htm EX-32.2 5786
17 dnli-20221231_g1.jpg GRAPHIC 398863
18 dnli-20221231_g10.jpg GRAPHIC 126568
19 dnli-20221231_g11.jpg GRAPHIC 107772
20 dnli-20221231_g12.jpg GRAPHIC 208483
21 dnli-20221231_g13.jpg GRAPHIC 181487
22 dnli-20221231_g14.jpg GRAPHIC 147937
23 dnli-20221231_g15.jpg GRAPHIC 126480
24 dnli-20221231_g16.jpg GRAPHIC 383726
25 dnli-20221231_g2.jpg GRAPHIC 103266
26 dnli-20221231_g3.jpg GRAPHIC 102464
27 dnli-20221231_g4.jpg GRAPHIC 152948
28 dnli-20221231_g5.jpg GRAPHIC 150549
29 dnli-20221231_g6.jpg GRAPHIC 164522
30 dnli-20221231_g7.jpg GRAPHIC 175483
31 dnli-20221231_g8.jpg GRAPHIC 157832
32 dnli-20221231_g9.jpg GRAPHIC 137480
  Complete submission text file 0001714899-23-000049.txt   17813946

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dnli-20221231.xsd EX-101.SCH 70974
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dnli-20221231_cal.xml EX-101.CAL 77809
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dnli-20221231_def.xml EX-101.DEF 318616
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dnli-20221231_lab.xml EX-101.LAB 821532
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dnli-20221231_pre.xml EX-101.PRE 536616
95 EXTRACTED XBRL INSTANCE DOCUMENT dnli-20221231_htm.xml XML 1628006
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38311 | Film No.: 23674764
SIC: 2836 Biological Products, (No Diagnostic Substances)